Skip to the page

Data / Form D filings / Nurture Genomics, Inc.

Nurture Genomics, Inc.: Form D filings

Nurture Genomics, Inc., a health care company in Cambridge, MA, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on September 9, 2025, reports $4.3 million sold of a $6 million offering to 40 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
CAMBRIDGE INNOVATION CENTER, 1 BROADWAY, Cambridge, MA, 02142
Phone
(617) 966-3216
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1949258

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 9, 2025Amendment$6,000,000$4,335,000$1,665,00040Sep 23, 2022sec.gov
Aug 8, 2023Amendment$5,000,000$1,705,000$3,295,00020Sep 23, 2022sec.gov
Oct 5, 2022New notice$3,000,000$355,000$2,645,0005Sep 23, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Steffanie BristolExecutive Officer
Robert C GreenExecutive Officer, Director
David C FeinbergExecutive Officer

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Sep 8, 2025 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Nurture Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.